November 16 from 12:30 pm – 1:15 pm EST
Theater A | Supported By: GSK
Program Description
Nearly half of patients with lupus will develop lupus nephritis. Please join us for a dynamic discussion on how to manage your SLE and LN patients. Our distinguished panel, Dr. Alfred Kim and Dr. Gerald Appel, will examine the disease burden of SLE and LN, and the potential for irreversible organ damage. The panel will review the role of the updated EULAR and KDIGO guidelines and how they play a part in the evolving clinical approach to disease management. The experts will also address the potential opportunity for the earlier use of advanced therapies for improving patient outcomes.
Speakers
Alfred Kim, MD, PhD
Washington University School of Medicine
Assistant Professor of Medicine Pathology and Immunology
St. Louis, Missouri
Gerald Appel, MD
Columbia University
Professor of Clinical Medicine & Director of Clinical Nephrology
New York, New York